Abaxis Company Profile (NASDAQ:ABAX)

About Abaxis

Abaxis, Inc. is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct sales force. The Company's segments are the medical market and the veterinary market. The Company's medical market products include Piccolo chemistry analyzers and consumable products. The Company develops, manufactures and sells the Piccolo Xpress chemistry analyzer for use in human patient care to provide clinicians with blood constituent measurements. The Company's veterinary market product offerings include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests.

Industry, Sector and Symbol:

Sector: Medical
Industry: Medical Laboratories & Research
Sub-Industry: Health Care Equipment
Exchange: NASDAQ
Symbol: ABAX
CUSIP: 00256710

Key Metrics:

Previous Close: $50.88
50 Day Moving Average: $49.85
200 Day Moving Average: $47.14
52-Week Range: $37.71 - $58.15
Trailing P/E Ratio: 37.00
Foreward P/E Ratio: 31.41
P/E Growth: 2.48
Market Cap: $1.15B
Outstanding Shares: 22,533,000
Beta: 1.02

Profitability:

Net Margins: 14.10%
Return on Equity: 13.03%
Return on Assets: 11.35%

Debt:

Current Ratio: 7.11%
Quick Ratio: 5.95%

Additional Links:

Companies Related to Abaxis:

Consensus Ratings for Abaxis (NASDAQ:ABAX) (?)

Ratings Breakdown:	3 Sell Ratings, 3 Hold Ratings
Consensus Rating:	Hold (Score: 1.50)
Consensus Price Target:	$41.25 (18.93% downside)

Analysts' Ratings History for Abaxis (NASDAQ:ABAX)

Show:

Date	Firm	Action	Rating	Price Target
8/16/2016	Credit Suisse Group AG	Reiterated Rating	Sell	$39.00
7/22/2016	Feltl & Co.	Downgrade	Hold -> Sell
4/19/2016	Canaccord Genuity	Reiterated Rating	Hold
4/1/2016	CL King	Initiated Coverage	Neutral
1/29/2016	Piper Jaffray Cos.	Lower Price Target	Neutral	$49.00 -> $45.00
10/21/2015	Bank of America Corp.	Downgrade	Neutral -> Underperform	$66.00 -> $39.00

(Data available from 9/28/2014 forward)

Earnings History for Abaxis (NASDAQ:ABAX)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/25/2016
7/21/2016	Q117	$0.32	$0.30	$58.70 million	$57.70 million	View	Listen
4/28/2016	Q416	$0.32	$0.36	$56.62 million	$57.00 million	View	Listen
1/28/2016	Q316	$0.33	$0.35	$58.52 million	$52.90 million	View	Listen
10/27/2015	Q216	$0.32	$0.34	$56.20 million	$56.00 million	View	Listen
7/23/2015	Q116	$0.28	$0.31	$53.75 million	$53.10 million	View	Listen
4/30/2015	Q415	$0.27	$0.17	$55.62 million	$52.00 million	View	N/A
1/29/2015	Q315	$0.25	$0.26	$51.70 million	$59.50 million	View	N/A
10/21/2014	Q215	$0.23	$0.39	$50.55 million	$53.90 million	View	Listen
7/24/2014	Q115	$0.19	$0.21	$46.95 million	$47.50 million	View	N/A
4/24/2014	Q414	$0.19	$0.17	$45.74 million	$42.04 million	View	N/A
1/31/2014	Q314	$0.20	$0.14	$49.47 million	$40.00 million	View	N/A
10/22/2013	Q114	$0.21	$0.18	$48.60 million	$45.90 million	View	N/A
7/25/2013	Q1 2014	$0.23	$0.14	$49.13 million	$43.20 million	View	Listen
4/25/2013	Q4 2013	$0.26	$0.30	$52.47 million	$50.00 million	View	Listen
1/31/2013	Q3 2013	$0.20	$0.22	$45.75 million	$49.80 million	View	Listen
10/23/2012		$0.18	$0.18			View	N/A
7/26/2012		$0.17	$0.13			View	N/A
4/26/2012		$0.16	$0.21			View	N/A
1/26/2012		$0.16	$0.13			View	N/A
10/25/2011		$0.14	$0.15			View	N/A
7/28/2011		$0.16	$0.10			View	N/A
4/28/2011		$0.16	$0.15			View	N/A
1/27/2011		$0.18	$0.17			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Abaxis (NASDAQ:ABAX)

Current Year EPS Consensus Estimate: $1.36 EPS
Next Year EPS Consensus Estimate: $1.62 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	5	$0.27	$0.35	$0.31
Q2 2016	2	$0.39	$0.40	$0.40
Q3 2016	3	$0.42	$0.44	$0.43
Q4 2016	1	$0.39	$0.39	$0.39
Q1 2017	1	$0.34	$0.34	$0.34
Q2 2017	1	$0.34	$0.34	$0.34
Q3 2017	1	$0.34	$0.34	$0.34
Q4 2017	1	$0.35	$0.35	$0.35
Q1 2018	1	$0.36	$0.36	$0.36
Q2 2018	1	$0.40	$0.40	$0.40
Q3 2018	1	$0.39	$0.39	$0.39
Q4 2018	1	$0.41	$0.41	$0.41

(Data provided by Zacks Investment Research)

Current Dividend Information for Abaxis (NASDAQ:ABAX)

Annual Dividend:	$0.48
Dividend Yield:	0.94%
Payout Ratio:	34.78% (Based on Trailing 12 Months of Earnings) 35.29% (Based on Current Year Consensus EPS Estimate) 29.63% (Based on Next Year Consensus EPS Estimate)

Dividend History for Abaxis (NASDAQ:ABAX)

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/21/2016	quarterly	$0.12	1.04%	8/30/2016	9/1/2016	9/15/2016
4/28/2016	quarterly	$0.12	1.06%	6/1/2016	6/3/2016	6/17/2016
1/28/2016	quarterly	$0.11	1.01%	3/1/2016	3/3/2016	3/17/2016
11/3/2015	quarterly	$0.11	0.84%	12/1/2015	12/3/2015	12/17/2015
7/23/2015	quarterly	$0.11	0.9%	9/1/2015	9/3/2015	9/17/2015
4/30/2015	quarterly	$0.11	0.79%	6/2/2015	6/4/2015	6/18/2015
1/30/2015	quarterly	$0.10	0.65%	2/27/2015	3/3/2015	3/17/2015
10/23/2014	quarterly	$0.10	0.82%	11/13/2014	11/17/2014	12/16/2014
7/24/2014	quarterly	$0.10	0.86%	8/29/2014	9/3/2014	9/17/2014
4/24/2014	quarterly	$0.10		5/30/2014	6/3/2014	6/17/2014
12/6/2012	special	$1.00		12/13/2012	12/17/2012	12/28/2012

(Data available from 1/1/2013 forward)

Insider Trading History for Abaxis (NASDAQ:ABAX)

Insider Ownership Percentage: 4.10%
Institutional Ownership Percentage: 99.03%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/9/2016	Clinton Severson	CEO	Sell	2,000	$48.29	$96,580.00
9/8/2016	Prithipal Singh	Director	Sell	1,000	$49.50	$49,500.00
8/25/2016	Prithipal Singh	Director	Sell	1,500	$50.30	$75,450.00
8/24/2016	Donald Peter Wood	Insider	Sell	8,500	$50.21	$426,785.00
6/9/2016	Richard Bastiani	Director	Sell	5,000	$46.75	$233,750.00
5/17/2016	Achim Henkel	Director	Sell	5,000	$44.43	$222,150.00
5/9/2016	Henk Evenhuis	Director	Sell	3,000	$45.00	$135,000.00
2/9/2016	Vernon E Altman	Director	Buy	303	$39.87	$12,080.61
12/8/2015	Craig Tockman	VP	Sell	560	$54.44	$30,486.40
2/9/2015	Prithipal Singh	Director	Sell	2,500	$60.50	$151,250.00
12/8/2014	Kenneth Aron	CTO	Sell	2,000	$56.68	$113,360.00
11/25/2014	Clinton Severson	CEO	Sell	2,286	$56.00	$128,016.00
11/13/2014	Clinton Severson	CEO	Sell	10,000	$55.00	$550,000.00
11/5/2014	Clinton Severson	CEO	Sell	10,000	$54.00	$540,000.00
11/3/2014	Alberto Santa Ines	CFO	Sell	1,652	$53.09	$87,704.68
11/3/2014	Clinton Severson	CEO	Sell	5,000	$53.00	$265,000.00
10/31/2014	Clinton Severson	CEO	Sell	10,000	$51.50	$515,000.00
8/12/2014	Richard Bastiani	Director	Sell	1,000	$45.40	$45,400.00
7/30/2014	Alberto Santa Ines	CFO	Sell	10,738	$47.81	$513,383.78
7/29/2014	Alberto Santa Ines	CFO	Sell	17,293	$48.01	$830,236.93
6/5/2014	Richard Bastiani	Director	Sell	2,000	$42.10	$84,200.00
6/3/2014	Richard Bastiani	Director	Sell	4,000	$41.88	$167,520.00
5/22/2014	Achim Henkel	Director	Sell	8,500	$41.63	$353,855.00
5/14/2014	Henk Evenhuis	Director	Sell	4,000	$44.06	$176,240.00
5/1/2014	Henk Evenhuis	Director	Sell	4,500	$41.00	$184,500.00
3/4/2014	Vladimir Ostoich	VP	Sell	9,800	$38.53	$377,594.00
2/24/2014	Kenneth Aron	CTO	Sell	1,000	$38.98	$38,980.00
2/13/2014	Donald Peter Wood	COO	Sell	8,864	$38.50	$341,264.00
6/7/2013	Clinton Severson	CEO	Sell	10,000	$44.50	$445,000.00
6/7/2013	Martin Mulroy	Insider	Sell	14,000	$44.80	$627,200.00
5/22/2013	Kenneth Aron	CTO	Sell	4,200	$43.28	$181,776.00
5/7/2013	Achim Henkel	Director	Sell	5,000	$44.07	$220,350.00
3/1/2013	Achim Henkel	Director	Sell	1,000	$42.85	$42,850.00
2/26/2013	Martin Mulroy	Insider	Sell	12,000	$41.84	$502,080.00
2/5/2013	Kenneth Aron	CTO	Sell	40,000	$44.13	$1,765,200.00
2/4/2013	Martin Mulroy	Insider	Sell	12,000	$43.97	$527,640.00
11/23/2012	Richard Bastiani	Director	Sell	5,000	$36.60	$183,000.00

(Data available from 1/1/2013 forward)

Latest Headlines for Abaxis (NASDAQ:ABAX)

Date	Headline
	Abaxis Has Returned 17.8% Since SmarTrend Recommendation (ABAX) (NASDAQ:ABAX) www.mysmartrend.com - September 24 at 3:10 PM
	ABAXIS, Inc. – Value Analysis (NASDAQ:ABAX) : September 21, 2016 (NASDAQ:ABAX) www.capitalcube.com - September 21 at 11:25 AM
	ABAXIS, Inc. breached its 50 day moving average in a Bullish Manner : ABAX-US : September 20, 2016 (NASDAQ:ABAX) www.capitalcube.com - September 20 at 3:03 PM
	The Top 100 U.S. in-Vitro Diagnostics Companies; New Report Launched (NASDAQ:ABAX) www.sbwire.com - September 15 at 12:04 PM
	Form DEF 14A ABAXIS INC For: Oct 26 (NASDAQ:ABAX) www.streetinsider.com - September 15 at 12:04 PM
	Learn details of the veterinary diagnostics market by products & technology (NASDAQ:ABAX) www.whatech.com - September 10 at 8:00 AM
	Abaxis, Inc. to Present at the 7th Annual Credit Suisse Small & Mid Cap Conference (NASDAQ:ABAX) finance.yahoo.com - September 8 at 12:12 PM
	Abaxis, Inc. to Present at the CL King 14th Annual Best Ideas Conference 2016 (NASDAQ:ABAX) finance.yahoo.com - September 7 at 12:10 PM
	Global Veterinary Diagnostics Market 2016: Hospitals and Clinics, Reference Laboratories (NASDAQ:ABAX) www.medgadget.com - September 6 at 8:00 AM
	ABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : ABAX-US : September 5, 2016 (NASDAQ:ABAX) www.capitalcube.com - September 5 at 3:09 PM
	Global Veterinary Diagnostics Market 2016: Hospitals and Clinics, Reference Laboratories, Universities/Research Institutions, Point-of-care (NASDAQ:ABAX) www.newsmaker.com.au - September 5 at 8:00 AM
	Farm Animal Diagnostics Market to Reach $4,215 million with 7.3% CAGR Forecast to 2022 (NASDAQ:ABAX) world.einnews.com - September 3 at 3:03 PM
	Point of Care (PoC) Lipid Test Market is Expected to Reach $280.02 Million by 2022 – Hexa Reports (NASDAQ:ABAX) www.abnewswire.com - August 31 at 3:10 PM
	ABAXIS INC : ex-dividend day (NASDAQ:ABAX) www.4-traders.com - August 29 at 8:22 PM
	Form 4 ABAXIS INC For: Aug 25 Filed by: SINGH PRITHIPAL (NASDAQ:ABAX) www.streetinsider.com - August 26 at 11:19 AM
	Ex-Dividend Reminder: Abaxis, McKesson and Universal Health Services (NASDAQ:ABAX) www.forbes.com - August 26 at 11:19 AM
	Abaxis Hurt by Dismal Q1 Results & Fierce Competition (NASDAQ:ABAX) finance.yahoo.com - August 26 at 11:19 AM
	New Strong Sell Stocks for August 23rd (NASDAQ:ABAX) finance.yahoo.com - August 23 at 3:00 PM
	Here’s The Growth Forecast For ABAXIS, Inc. (NASDAQ:ABAX) (NASDAQ:ABAX) www.realistinvestor.com - August 17 at 3:10 PM
	ABAXIS INC Financials (NASDAQ:ABAX) finance.yahoo.com - August 16 at 3:12 PM
	North America PoC Diagnostics Market Is Projected To Reach $8.95 Billion By 2024: Grand View Research, Inc. (NASDAQ:ABAX) www.abnewswire.com - August 16 at 11:51 AM
	New Strong Sell Stocks for August 15th (NASDAQ:ABAX) finance.yahoo.com - August 15 at 10:28 AM
	"Abaxis, Inc. (ABAX) - Financial and Strategic SWOT Analysis Review" now available at Fast Market Research (NASDAQ:ABAX) www.live-pr.com - August 11 at 9:05 PM
	North America PoC Diagnostics Market Worth $8.95 Billion By 2024 (NASDAQ:ABAX) forextv.com - August 10 at 11:47 AM
	Global Companion Animal Diagnostics Market 2016 to grow at a CAGR of 8.84 % by 2022 : Market Research Store (NASDAQ:ABAX) www.medgadget.com - August 5 at 11:34 AM
	New Strong Sell Stocks for August 5th (NASDAQ:ABAX) finance.yahoo.com - August 5 at 11:33 AM
	Abaxis, Inc. to Present at the Canaccord Genuity 36th Annual Growth Conference (NASDAQ:ABAX) finance.yahoo.com - August 4 at 11:44 AM
	New Study: 2016 Global Point-Of-Care Diagnostics / Testing (POCT) Market (NASDAQ:ABAX) www.medgadget.com - July 29 at 3:06 PM
	Veterinary Diagnostics Market by Product by Technology by Animal - Global forecast to 2021 (NASDAQ:ABAX) www.prnewswire.com - July 26 at 3:02 PM
	ABAXIS, Inc. :ABAX-US: Earnings Analysis: Q1, 2017 By the Numbers : July 26, 2016 (NASDAQ:ABAX) www.capitalcube.com - July 26 at 9:57 AM
	ABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : ABAX-US : July 25, 2016 (NASDAQ:ABAX) www.capitalcube.com - July 25 at 8:34 AM
	Abaxis (ABAX) Q1 Earnings Miss Estimates, Sales Up Y/Y (NASDAQ:ABAX) finance.yahoo.com - July 22 at 1:06 PM
	Abaxis Reports Financial Performance for the First Quarter of Fiscal 2017 and Declares a Quarterly Cash Dividend (NASDAQ:ABAX) www.prnewswire.com - July 21 at 8:49 PM
	Abaxis Inc. Q1 Income Falls 2% (NASDAQ:ABAX) www.nasdaq.com - July 21 at 8:49 PM
	Abaxis misses Street 1Q forecasts (NASDAQ:ABAX) sg.finance.yahoo.com - July 21 at 4:40 PM
	Q1 2017 Abaxis Inc Earnings Release - After Market Close (NASDAQ:ABAX) biz.yahoo.com - July 21 at 7:07 AM
	Medical Product Earnings on Jul 21: ABAX, ATHN, NURO, SYK (NASDAQ:ABAX) finance.yahoo.com - July 20 at 10:18 AM
	Farm Animal Diagnostics Market Size, Analysis, Report, Trends, Share, Opportunities and Forecast To 2022 (NASDAQ:ABAX) itbusinessnet.com - July 15 at 7:28 PM
	Abaxis To Report First Quarter Fiscal Year 2017 Financial Results On Thursday, July 21, 2016 (NASDAQ:ABAX) www.publicnow.com - July 13 at 8:33 AM
	Curetis: Curetis Appoints Christopher M. Bernard as Chief Executive Officer of Newly-Formed U.S. Subsidiary (NASDAQ:ABAX) www.finanznachrichten.de - July 5 at 3:12 PM
	YieldBoost ABAX To 12.9% Using Options (NASDAQ:ABAX) www.nasdaq.com - June 29 at 3:00 PM
	Veterinary Laboratory Testing Services Market - Latest Innovations, Drivers, Restraints, Challenges and Forecast 2016-2024 (NASDAQ:ABAX) www.sbwire.com - June 29 at 11:07 AM
	Unleashed: A Wave Of Pet-Friendly Services & Innovations (NASDAQ:ABAX) www.investors.com - June 24 at 12:53 PM
	Point of Care Diagnostics Market Worth $20.9 Billion by 2024: Grand View Research, Inc. (NASDAQ:ABAX) www.finanznachrichten.de - June 22 at 8:00 AM
	Veterinary Diagnostics 2016 Global Market Share,Supply,Consupmtion and Market Opportunities Research Report Forecasting to 2022 (NASDAQ:ABAX) www.newsmaker.com.au - June 22 at 8:00 AM
	ABAXIS, Inc. – Value Analysis (NASDAQ:ABAX) : June 21, 2016 (NASDAQ:ABAX) www.capitalcube.com - June 21 at 11:20 AM
	ABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : ABAX-US : June 20, 2016 (NASDAQ:ABAX) www.capitalcube.com - June 20 at 8:34 AM
	Veterinary Diagnostics Market Worth 6.71 Billion USD by 2021 (NASDAQ:ABAX) finance.yahoo.com - June 17 at 8:09 PM
	Global Top 200 Point-Of-Care Diagnostics Companies: Competitive Analysis, Financial Analysis and Strategic Alliance Identification (NASDAQ:ABAX) www.medgadget.com - June 12 at 3:12 PM
	Form 4 ABAXIS INC For: Jun 08 Filed by: BASTIANI RICHARD (NASDAQ:ABAX) www.streetinsider.com - June 11 at 8:41 PM